Yale Medicine School: Herold is New Chair of International Diabetes Consortium
June 11, 2021
June 11, 2021
NEW HAVEN, Connecticut, June 11 (TNSPer) -- Yale School of Medicine issued the following news:
Kevan C. Herold, MD, C.N.H. Long Professor of Immunobiology and professor of medicine (endocrinology) at Yale School of Medicine, has been named chair of Type 1 Diabetes (T1D) TrialNet, an international consortium dedicated to finding ways to prevent, delay, and slow progression of the disease, in which the immune system mistakenly attacks and destroys healthy insulin-producing cells. Tria . . .
Kevan C. Herold, MD, C.N.H. Long Professor of Immunobiology and professor of medicine (endocrinology) at Yale School of Medicine, has been named chair of Type 1 Diabetes (T1D) TrialNet, an international consortium dedicated to finding ways to prevent, delay, and slow progression of the disease, in which the immune system mistakenly attacks and destroys healthy insulin-producing cells. Tria . . .